Marijuana is now legal in many places, but is it safe? Two new studies add to mounting evidence that people who use cannabis are more likely to suffer a heart attack than people who do not use the ...

AI workflows fundamentally depend on real-time data movement: ingesting training data streams, feeding live data to models for inference and distributing predictions back to applications. But strip ...

Abstract: This study reports on the progress in designing and developing a framework for integrating heterogeneous datasets—structured, semi-structured, and unstructured—into an AI-ready multimodal ...

Abstract: Federated Learning (FL) facilitates collaborative learning among multiple clients in a distributed manner and ensures the security of privacy. However, its performance inevitably degrades ...

Artificial intelligence has developed rapidly in recent years, with tech companies investing billions of dollars in data centers to help train and run AI models. The expansion of data centers has ...

The first half of this year was the costliest ever recorded for weather and climate disasters in the United States, according to an analysis published Wednesday by the nonprofit organization Climate ...

Runs on Python 3.8 or higher on Windows, Linux and MacOS. To run an example using an image-only dataset, create a file named example_image.py with the following contents in the same directory that ...

TUCSON, Ariz. (13 News) - There was a protest outside a fundraiser for the Pima County Democrats on Tucson’s northeast side on Monday, Oct. 20. People gathered to put pressure on Pima County ...

PLAINSBORO, N.J., and BAGSVÆRD, Denmark, Oct. 20, 2025 /PRNewswire/ -- Novo Nordisk today announced new data on the investigational oral semaglutide 25 mg will be among 23 abstracts to be presented at ...

This article originally appeared on The Conversation. Powder and ready-to-drink protein sales have exploded, reaching over $32 billion globally from 2024 to 2025. Increasingly, consumers are using ...

Europe’s leading cancer conference may be swimming in antibody-drug conjugate data, but AstraZeneca remains convinced that its in-house pipeline sets the pharma apart. The U.K.-based drugmaker earned ...